Leerink Partners Reiterates Outperform Rating on Cencora, Inc. (COR)

Market Context

Cencora, Inc. operates in the Healthcare sector. The stock currently trades at $339.68 with a market capitalization of $66.7B. The stock has gained 1.2% over the past 52 weeks.

Analyst coverage from Leerink Partners provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Cencora, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Cencora, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Nov 05, 2026	Leerink Partners	Outperform	N/A
Nov 05, 2026	Evercore ISI Group	Outperform	N/A
Oct 30, 2026	Morgan Stanley	Overweight	N/A
Oct 22, 2026	Baird	Outperform	N/A
Oct 20, 2026	Argus Research	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View COR Stock Page